Becker's Healthcare January 22, 2024
Intermountain Health will end and divest its Precision Genomics Laboratory Feb. 1.
The 33-hospital system introduced Intermountain Precision Genomics in 2014. “Over the past 10 years, the precision medicine market has rapidly evolved, new partners have entered, and this work has become financially unsustainable,” the nonprofit health system said.
IPG offers genetic sequencing for patients with advanced cancers to identify specific DNA targets for personalized drugs. Intermountain has said the program has been financially unsustainable for several years. The system cut 38 jobs within IPG last year in an attempt to reverse course and redesign the model from one of long-term research to one focused on patient application.
Less than a year later, the system announced its decision...
Today's Sponsors
Today's Sponsor